BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8819585)

  • 21. Evaluation of triazolamers as active site inhibitors of HIV-1 protease.
    Jochim AL; Miller SE; Angelo NG; Arora PS
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6023-6. PubMed ID: 19800230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kynostatin (KNI)-272--a rationally designed tripeptide inhibitor of HIV protease].
    Kiso Y
    Nihon Rinsho; 1993 Sep; 51 Suppl():139-45. PubMed ID: 8271377
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination therapy in the management of HIV infection.
    Vella S; Franca Pirillo M
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl C():23-6. PubMed ID: 9003571
    [No Abstract]   [Full Text] [Related]  

  • 24. Second-generation drugs fight resistant virus.
    STEP Perspect; 1999; 99(1):3. PubMed ID: 11367160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance.
    Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezácová P; Brynda J; Pokorná J; Plesek J; Grüner B; Grantz Sasková K; Václavíková J; Král V; Konvalinka J
    J Med Chem; 2008 Aug; 51(15):4839-43. PubMed ID: 18598016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1protease activity.
    Wei Y; Ma CM; Hattori M
    Eur J Med Chem; 2009 Oct; 44(10):4112-20. PubMed ID: 19493591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.
    Venturi G; Catucci M; Romano L; Corsi P; Leoncini F; Valensin PE; Zazzi M
    J Infect Dis; 2000 Feb; 181(2):740-5. PubMed ID: 10669367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies on inhibitors of HIV protease: a target for drug design.
    Jayaraman S; Shah K
    In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invirase resistance/cross-resistance data released.
    AIDS Patient Care STDS; 1996 Jun; 10(3):185. PubMed ID: 11361626
    [No Abstract]   [Full Text] [Related]  

  • 30. Protease inhibitors: resistance, resistance, resistance.
    Gilden D; Falkenberg J; Torres G
    GMHC Treat Issues; 1997 Feb; 11(2):5-10. PubMed ID: 11364108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HIV: to administer protease inhibitors early].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916
    [No Abstract]   [Full Text] [Related]  

  • 32. A hierarchical model of HIV-1 protease drug resistance.
    Goodsell DS
    Appl Bioinformatics; 2002; 1(1):3-12. PubMed ID: 15130852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-resistant HIV: predicting the future.
    Laurence J
    AIDS Read; 2001 Oct; 11(10):485-6. PubMed ID: 11708079
    [No Abstract]   [Full Text] [Related]  

  • 34. Interview with Celia Schiffer.
    Schiffer C
    Future Med Chem; 2013 Jul; 5(11):1193-7. PubMed ID: 23859201
    [No Abstract]   [Full Text] [Related]  

  • 35. Protease inhibitors.
    Treat Rev; 1995; (no 19):2. PubMed ID: 11362753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From SAR to comparative QSAR: role of hydrophobicity in the design of 4-hydroxy-5,6-dihydropyran-2-ones HIV-1 protease inhibitors.
    Bhhatarai B; Garg R
    Bioorg Med Chem; 2005 Jun; 13(12):4078-84. PubMed ID: 15911321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus.
    Lu Z; Bohn J; Rano T; Rutkowski CA; Simcoe AL; Olsen DB; Schleif WA; Carella A; Gabryelski L; Jin L; Lin JH; Emini E; Chapman K; Tata JR
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5311-4. PubMed ID: 16203148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of HIV-1 protease inhibitor resistance by Molecular Modeling Protocols (MMPs) using GenMol software.
    Pèpe G; Courcambeck J; Perbost R; Jouanna P; Halfon P
    Eur J Med Chem; 2008 Nov; 43(11):2518-34. PubMed ID: 18455274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive inhibitors of the HIV-1 protease.
    Ohtaka H; Freire E
    Prog Biophys Mol Biol; 2005 Jun; 88(2):193-208. PubMed ID: 15572155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral resistance to protease inhibitors.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):1, 4-5. PubMed ID: 11362685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.